Europe Diabetes Care Devices Market Share, Trends, Revenue, Demand, Key Manufacturers, Challenges, Future Strategy and Growth Opportunities till 2033


Europe Diabetes Care Devices Market Share, Trends, Revenue, Demand, Key Manufacturers, Challenges, Future Strategy and Growth Opportunities till 2033: SPER Market Research

 Category : Medical Devices

 Published: Apr-2024
 Author: SPER Analyst

Europe Diabetes Care Devices Market is projected to be worth USD XX billion by 2033 and is anticipated to surge at a CAGR of XX%.

Diabetes arises when the pancreas fails to make insulin from blood. Untreated diabetes is caused by elevated blood sugar levels. Diabetes medications are particularly designed to treat diabetes. Diabetic treatment seeks to raise blood glucose levels. Care for diabetes gadgets monitor diabetic' blood glucose levels. A continuous glucose monitor (CGM) is a medical device that tracks and monitors diabetes patients' blood sugar levels all day. This wearable device will help diabetics manage blood glucose levels.

Europe Diabetes Care Devices Market Driving Factors and Challenges

Drivers: An increase in obesity One of the main risk factors for diabetes in people is obesity. The WHO estimates that in 2014, about 20% of Europeans were fat and almost 50% of people were overweight. Male obesity is more prevalent. A high diabetes prevalence is the consequence of risk factors that are directly linked to the rising prevalence of diabetes, such as the rising prevalence of obesity. The market for diabetes devices is expanding as a result growing understanding of managing diabetes Throughout the course of the forecast period, this market is anticipated to develop due to a number of factors, including an increasing number of patients with diabetes and more awareness about diabetes management and control.

Challenges: The Europe Diabetes Care Devices Market is faced with multiple challenges. An important issue is the rising incidence of diabetes in the area, which is being caused by aging populations, sedentary lifestyles, and poor eating habits. The increased number of diabetes cases strains healthcare systems, necessitating effective resource management and allocation to meet the rising demand for diabetes care products and services. Furthermore, different European nations have different reimbursement practices and regulatory frameworks, which makes it difficult for device makers to enter and grow new markets.

Impact of COVID-19 on Europe Diabetes Care Devices Market
The COVID-19 pandemic impeded the growth of the diabetic care equipment market. Infection with COVID-19 caused a rise in blood glucose levels. Elevated blood glucose levels brought on by the stress of infection and the use of steroids for COVID-19 treatment contributed to the rise in the number of patients. Market leaders undoubtedly gained from these opportunities. Many players have signed partnerships and agreements linked to diabetes care devices and introduced new state-of-the-art gadgets in response to the rising prevalence of diabetes. Lockdowns and travel restrictions disrupted the supply chain, which in turn resulted in a shortage of diabetic care equipment, even if this only had a temporary impact on the market.

Europe Diabetes Care Devices Market Key Players:
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players are; Abbott Diabetes Care, Agamatrix Inc., Ascensia Diabetes Care, Bionime Corporation, Dexcom Inc., Eli Lilly, Insulet Corporation, Medtronic, LifeScan, Novo Nordisk A/S, Roche Diabetes Care, Rossmax, Sanofi, Others.

Europe Diabetes Care Devices Market Segmentation:

By Monitoring Devices: Based on the Monitoring Devices, Europe Diabetes Care Devices Market is segmented as; Self-monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices.

By Management Devices: Based on the Management Devices, Europe Diabetes Care Devices Market is segmented as; Insulin Pump, Insulin Syringes, Cartridges in Reusable Pens, Insulin Disposable Pens, Jet Injectors.

By Region: This research also includes data for UK, France, Germany, Italy, Spain, Rest of Europe.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Johnson & Johnson


Market Research

We are the leading, full-service global market research and consulting company.

iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]